Fludarabine Monophosphate, an Effective New Agent in Leukaemias and Lymphomas
作者： Gerassimos A. Pangalis , Maria K. Angelopoulou , Christos Poziopoulos , Aaron Polliack , Shamuel Gillis
DOI: 10.1007/978-3-642-79913-6_11
关键词: Fludarabine monophosphate 、 Refractory 、 Fludarabine Phosphate 、 Fludarabine 、 Cancer research 、 Refractory Chronic Lymphocytic Leukemia 、 Mycosis fungoides 、 Chronic lymphocytic leukemia 、 Medicine 、 Purine analogue
摘要: Chronic lymphocytic leukaemia and low-grade non-Hodgkin’s lymphomas are diseases for which until recently no treatment leading to long lasting complete remission or cure existed. Fludarabine monophosphate, a purine analogue, was introduced into clinical trials chronic found be very effective. In this report we review the available data relating fludarabine monophosphate present our experience with administration in refractory B-chronic lymphoma Athens Jerusalem.
springer.com
sci-hub.st 参考文章(63)
MJ Keating, H Kantarjian, M Talpaz, J Redman, C Koller, B Barlogie, W Velasquez, W Plunkett, EJ Freireich, KB McCredie, Fludarabine: a new agent with major activity against chronic lymphocytic leukemia Blood. ,vol. 74, pp. 19- 25 ,(1989) , 10.1182/BLOOD.V74.1.19.19
C.H. Chang, R.W. Brockman, L.L. Bennett, Adenosine kinase from L1210 cells. Purification and some properties of the enzyme. Journal of Biological Chemistry. ,vol. 255, pp. 2366- 2371 ,(1980) , 10.1016/S0021-9258(19)85900-8
Maria K. Angelopoulou, Gerassimos A. Pangalis, Treatment of Low-Grade Non-Hodgkin’s Lymphomas Springer, Berlin, Heidelberg. pp. 75- 102 ,(1995) , 10.1007/978-3-642-79913-6_7
Balcerzak Sp, Kopecky Kj, Hutton Jj, Grever Mr, Greenberg Br, Talley R, Von Hoff Dd, Coltman Ca, Files Jc, Fludarabine monophosphate: a potentially useful agent in chronic lymphocytic leukemia. Nouvelle revue française d'hématologie. ,vol. 30, pp. 457- 459 ,(1988)
HM Kantarjian, R Alexanian, CA Koller, R Kurzrock, MJ Keating, Fludarabine therapy in macroglobulinemic lymphoma Blood. ,vol. 75, pp. 1928- 1931 ,(1990) , 10.1182/BLOOD.V75.10.1928.1928
S O'Brien, H Kantarjian, M Beran, T Smith, C Koller, E Estey, LE Robertson, S Lerner, M Keating, Results of Fludarabine and Prednisone Therapy in 264 Patients With Chronic Lymphocytic Leukemia With Multivariate Analysis-Derived Prognostic Model for Response to Treatment Blood. ,vol. 82, pp. 1695- 1700 ,(1993) , 10.1182/BLOOD.V82.6.1695.1695
Eric H. Kraut, Louis Malspeis, Kathy M. Snider, Michael R. Grever, Earl N. Metz, Jane M. Leiby, Phase II trial of 9-beta-D-arabinofuranosyl-2-fluoroadenine 5'-monophosphate in non-Hodgkin's lymphoma: prospective comparison of response with deoxycytidine kinase activity. Cancer Research. ,vol. 47, pp. 2719- 2722 ,(1987)
Daniel D. Von Hoff, David H. Boldt, John G. Kuhn, Marla Hersh, Effects on Human Peripheral Lymphocytes of in Vivo Administration of 9-ß -D-Arabinofuranosyl-2-fluoroadenine-5'-monophosphate (NSC 312887), a New Purine Antimetabolite Cancer Research. ,vol. 44, pp. 4661- 4666 ,(1984)
P Huang, S Chubb, W Plunkett, Termination of DNA synthesis by 9-beta-D-arabinofuranosyl-2-fluoroadenine. A mechanism for cytotoxicity. Journal of Biological Chemistry. ,vol. 265, pp. 16617- 16625 ,(1990) , 10.1016/S0021-9258(17)46267-3
M J Keating, H Kantarjian, S O'Brien, C Koller, M Talpaz, J Schachner, C C Childs, E J Freireich, K B McCredie, Fludarabine: a new agent with marked cytoreductive activity in untreated chronic lymphocytic leukemia. Journal of Clinical Oncology. ,vol. 9, pp. 44- 49 ,(1991) , 10.1200/JCO.1991.9.1.44